Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2004
06/10/2004US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening
06/10/2004US20040110179 Method for alteration detection
06/10/2004US20040110178 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use
06/10/2004US20040110177 Method for identifying functional nucleic acids
06/10/2004US20040110173 Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene
06/10/2004US20040110169 Method for rapid detection and identification of bioagents
06/10/2004US20040110168 Diagnostics and therapeutics for osteoporosis
06/10/2004US20040110167 Rapid and accurate detection of amplified and nonamplified nucleic acid sequences while being simple, economical and ready to use; self-contained; device contains all reagents necessary for the assay in an anhydrous format
06/10/2004US20040110166 Identifying and quantifying genetic aberration at multiple genetic loci; restriction fragment length polymorphism analysis
06/10/2004US20040110163 Preparing molecular conductive wire comprising nucleic acids forming a central canal composed of linearly arranged metal ions within the canal and an electron-rich external surface
06/10/2004US20040110162 Primer extension methods for detecting nucleic acids
06/10/2004US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics
06/10/2004US20040110155 Modulation of SLC26A2 expression
06/10/2004US20040110153 Enriching, replicating and genotyping preferential restriction fragment lenght polymorphisms using specific oligonucleotides, adaptor molecules and rolling circle replication
06/10/2004US20040110152 Antisense oligonucleotides for controlling expression of zinc-dependent endopeptidase and for treatment of hyperproliferative disorders
06/10/2004US20040110151 Modulation of sentrin-2 expression
06/10/2004US20040110150 Antisense oligonucleotides for controlling expression of tyrosine kinase interacting protein (EPHRIN-B2) and for treatment of hyperproliferative disorders
06/10/2004US20040110149 Modulation of BUB1-beta expression
06/10/2004US20040110148 Antisense oligonucleotides for controlling expression of polyamine biosynthetic enzymes and for treating hyperproliferative disorders
06/10/2004US20040110146 Antisense oligonucleotides for controlling expression of cell surface adhesion molecule and for treatment of autoimmune disorders
06/10/2004US20040110145 Modulation of MALT1 expression
06/10/2004US20040110144 Modulation of EMAP-II expression
06/10/2004US20040110143 Antisense oligonucleotides for controlling expression of liver receptor homologue -1 (LRH-1) for treatment of hyperproliferative disorders
06/10/2004US20040110141 Nucleic acid detector and method of detecting targets within a sample
06/10/2004US20040110138 Method for the detection of multiple genetic targets
06/10/2004US20040110137 Using fluorescent-light intensity waveform data to determine sequence of target nucleic acids; identifying restriction fragment length polymorphisms
06/10/2004US20040110135 Method for producing linear DNA fragments for the in vitro expression of proteins
06/10/2004US20040110134 Methods for quantitating nucleic acids using coupled ligation and amplification
06/10/2004US20040110129 Using mycobacterium-specific oligonucleotides and DNA amplifcation to detect infectious microorganisms
06/10/2004US20040110128 Comprises tagged nanoparticles associated with specific integrated circuits and ligated to oligonucleotide for use as diagnostic tools in DNA sequencing
06/10/2004US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell
06/10/2004US20040110126 Hcv polymerase inhibitor assay
06/10/2004US20040110125 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
06/10/2004US20040110124 Method of enhancing radiation resistance of normal cells
06/10/2004US20040109868 Pim kinase-related methods
06/10/2004US20040109858 Conformation-specific anti-von Willebrand factor antibodies
06/10/2004US20040109848 Modulation of AP-2 alpha expression
06/10/2004US20040108206 Biosensor
06/10/2004CA2721200A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
06/10/2004CA2704070A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
06/10/2004CA2691447A1 Ca ix-specific inhibitors
06/10/2004CA2589836A1 Target for therapy of cognitive impairment
06/10/2004CA2547331A1 Electro-optical nucleic acid-based sensor array and method for detecting analytes
06/10/2004CA2518381A1 Mracs as modifiers of the rac pathway and methods of use
06/10/2004CA2511481A1 Method of designing polynucleotides for rna interference
06/10/2004CA2509769A1 Sampling method and apparatus for amplification reaction analysis
06/10/2004CA2507469A1 Porcine polymorphisms and methods for detecting them
06/10/2004CA2507165A1 Optical information carrier comprising immobilized proteorhodopsin
06/10/2004CA2507018A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders
06/10/2004CA2506985A1 Preparation of polyphosphazene microspheres
06/10/2004CA2506959A1 Loc169505 as modifier of the apc and axin pathways and methods of use
06/10/2004CA2506805A1 Methods for using primers that encode one strand of a double-stranded promoter
06/10/2004CA2506798A1 Compositions and systems for the regulation of genes
06/10/2004CA2506738A1 Composition for treating chlamydia infections and method for identifying same
06/10/2004CA2506707A1 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use
06/10/2004CA2506686A1 Cct6s as modifiers of the rb pathway and methods of use
06/10/2004CA2506683A1 Compositions and methods for cell dedifferentiation and tissue regeneration
06/10/2004CA2506666A1 Nact as a target for lifespan expansion and weight reduction
06/10/2004CA2506634A1 Csnks as modifiers of the rac pathway and methods of use
06/10/2004CA2506513A1 Sol-gel biosensors
06/10/2004CA2506411A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
06/10/2004CA2506260A1 Method of immobilizing biomolecule to metallic carrier
06/10/2004CA2506197A1 Detection of protease enzymes
06/10/2004CA2506194A1 Target for therapy of cognitive impairment
06/10/2004CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof
06/10/2004CA2505764A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same
06/10/2004CA2505416A1 Methods for diagnosing rcc and other solid tumors
06/10/2004CA2504856A1 Inferring gene regulatory networks from time-ordered gene expression data using differential equations
06/10/2004CA2504633A1 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
06/10/2004CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7
06/10/2004CA2503246A1 Compositions and methods for diagnosing and treating mood disorders
06/10/2004CA2485950A1 Methods for cohort selection and longevity studies
06/10/2004CA2476691A1 Novel proteins and nucleic acids encoding same
06/10/2004CA2452785A1 Sequence display method and homology search method for facilitating access to information relating to regions of mutation and regions of similarity between plurality of sequences
06/09/2004EP1426767A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (PDE4C)
06/09/2004EP1426757A1 Method, tool and device for measuring concentration
06/09/2004EP1426449A1 Method of evaluating degree of canceration of mammal-origin specimen
06/09/2004EP1426448A1 Method for lowering the effects of sequence variations in a diagnostic hybridization assay, probe for use in the assay and assay
06/09/2004EP1426447A1 Method for the detection of pathogenic gram positive bacteria selected from the genera Staphylococcus, Enterococcus and Streptococcus
06/09/2004EP1426439A1 Method of detecting toxic substance
06/09/2004EP1426438A1 Method of detecting toxic substance
06/09/2004EP1426381A1 An epithelial protein and DNA thereof for use in early cancer detection
06/09/2004EP1426110A2 Temperature-regulating block with temperature-regulating devices
06/09/2004EP1426054A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof
06/09/2004EP1425696A2 Methods for differential cell counts including related apparatus and software for performing same
06/09/2004EP1425695A2 Method and system for profiling biological systems
06/09/2004EP1425589A2 Differential diagnosis of disorders of iron metabolism
06/09/2004EP1425587A2 Method for identifying anti-inflammatory drugs
06/09/2004EP1425585A2 Lateral flow test format for enzyme assays
06/09/2004EP1425581A2 Bio-sensing platforms for detection and quantitation of biological molecules
06/09/2004EP1425575A1 A novel cancer marker and uses therefor in the diagnosis of cancer
06/09/2004EP1425568A2 Particle analysis as a detection system for particle-enhanced assays
06/09/2004EP1425548A2 Microcantilever apparatus and methods for detection of enzymes
06/09/2004EP1425422A2 Nucleic acid amplification
06/09/2004EP1425420A1 Molecular identification of staphylococcus-type bacteria
06/09/2004EP1425419A2 Electrochemical sensor using intercalative, redox-active moieties
06/09/2004EP1425418A2 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
06/09/2004EP1425417A2 Interaction detection on several probe arrays
06/09/2004EP1425416A2 A high throughput method for identification of sequence tags
06/09/2004EP1425415A2 Polymorphisms associated with ion-channel disease